Insider Holders & Insider Ownership - PDL BIOPHARMA INC. (PDLI)

List of insiders holdings for PDL BIOPHARMA INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Silver Point Capital L.P.
O'Shea Robert J
MULE EDWARD A
10% Owner		2021-02-03 17:57:5423,970,334
0		23,970,334Form 4
Park West Asset Management LLC
10% Owner		2021-01-11 16:32:370
14,397,212		14,397,212Form 3
QUEEN CARY L
Director		2005-12-28 12:01:201,991,800
17,600		2,009,400Form 4
Hasnain Faheem
President & CEO		2008-10-03 10:56:22775,000
0		775,000Form 4
Monnet Dominique
President and CEO		2020-12-17 16:48:55734,921
0		734,921Form 4
GARCIA PETER S
Vice President, CFO		2019-04-16 17:16:40641,025
0		641,025Form 4/A
SAXE JON S
Director		2008-04-10 10:41:21421,680
0		421,680Form 4
Stone Christopher Lewis
VP, Gen. Counsel & Secretary		2020-12-17 16:49:14405,559
0		405,559Form 4
Hart Danny J Jr.
VP Business Development		2017-03-07 20:18:11387,236
0		387,236Form 4
Imbrogno Edward
VP Finance, CAO and Acting CFO		2020-04-07 08:47:46314,565
0		314,565Form 4/A
Lindell Jody S
Director		2018-06-12 16:30:20256,174
0		256,174Form 4
Edick Paul R
Director		2018-06-12 16:29:50214,563
0		214,563Form 4
MCLAUGHLIN JOHN PETER
Director		2020-12-22 19:51:33200,000
0		200,000Form 4
Jene Jill M.
VP, Business Development		2020-04-07 08:46:58194,805
0		194,805Form 4/A
Hernday Natasha
Director		2020-08-24 06:06:26194,497
0		194,497Form 4
Pietzke Steffen
VP, Finance and CAO		2017-12-19 20:03:53139,587
20,590		160,177Form 4
Saks Samuel R
Director		2019-06-24 21:40:43126,050
0		126,050Form 4
Yanai Shlomo
Director		2019-06-24 21:44:19126,050
0		126,050Form 4
Sandman Paul W
Director		2019-06-24 21:36:13126,050
0		126,050Form 4
SELICK HAROLD E
Director		2019-06-24 21:39:28126,050
0		126,050Form 4
SATO GLEN Y
SVP and CFO		2005-05-26 17:26:57116,738
0		116,738Form 4
KLEIN JOSEPH III
Director		2009-11-06 13:29:22109,899
11		109,910Form 4
NAJAFI BEHROOZ
V.P. IS and Corporate Services		2003-07-29 20:02:56100,000
0		100,000Form 4
Hora Maninder
VP of Product Operations		2008-08-20 15:57:0584,657
0		84,657Form 3
MURRAY RICHARD
EVP & CSO		2008-07-22 18:06:3770,159
0		70,159Form 4
JUE GEORGE
VP of Finance		2006-11-16 16:25:0964,501
0		64,501Form 4
LARSON CHRISTINE R
Vice President and CFO		2011-05-25 20:20:5362,049
0		62,049Form 4
EBERSOLE DOUGLAS O
SVP, Legal & Corp. Dev.		2004-07-26 18:15:5550,000
0		50,000Form 4
MCDADE MARK
CEO		2007-07-24 17:38:3846,275
0		46,275Form 4
TORRES LAURIE C
VP, Corporate Services		2007-04-17 14:59:3544,072
0		44,072Form 4
FRANK FRED
Director		2012-06-06 18:24:0033,296
0		33,296Form 4
BENNER STEVEN E
SVP & Chief Med. Off.		2006-07-24 18:26:4328,427
0		28,427Form 4
OLSON LYN D
VP, Quality & Compliance		2004-07-26 18:44:4327,000
0		27,000Form 4
Montez David
Controller and CAO		2015-01-30 16:02:3226,719
0		26,719Form 4
Broder Samuel
Director		2007-06-22 17:32:0626,500
0		26,500Form 4
Goodwin Bradford S
Chairperson of the Board		2008-07-17 17:26:0325,000
0		25,000Form 4
GARCIA RODRIGUEZ SERGIO
VP, Legal and General Counsel		2004-07-26 19:39:0325,000
0		25,000Form 4
KORN LAURENCE JAY
Director		2008-05-30 18:07:4824,000
0		24,000Form 4
GAGE L PATRICK
Interim CEO		2008-04-30 14:22:0419,555
0		19,555Form 4
Tomlinson Bruce
Chief Financial Officer		2012-06-21 18:41:5816,509
0		16,509Form 4
SHAH JAISIM
SVP, Mktg & Bus. Affairs		2008-04-30 14:25:5616,125
0		16,125Form 4
McCamish Mark Anthony
SVP & CMO		2008-12-19 14:31:1214,924
0		14,924Form 4
SCHMIDLI BRETT L
SVP, Technical Operations		2005-09-08 18:40:0714,500
0		14,500Form 4
GOULD GEORGE M
Director		2004-07-01 20:22:0814,000
0		14,000Form 4
GUGGENHIME ANDREW
SVP & Chief Financial Officer		2008-12-19 12:48:1313,255
0		13,255Form 4
WILSON KAREN J
VP of Finance & PAO		2009-05-11 13:20:5310,494
0		10,494Form 4
Bazaar Alan Lee
Director		2020-11-20 20:22:0210,438
0		10,438Form 4
CHARLSON FRANCES G
VP, Human Resources		2003-07-01 17:39:1510,000
0		10,000Form 4
BENJAMIN WILLIAM R
VP, Research & Clinical Tech		2003-07-01 17:10:2210,000
0		10,000Form 4
Savel Robert Michael II
SVP Technical Operations		2007-08-17 17:46:4710,000
0		10,000Form 4
Shumate Cynthia Lynn
VP Legal Affrs, Secy & CCO		2007-08-17 17:53:5210,000
0		10,000Form 4
KRUMEL CAROLINE J
VPFinance/Prin.Accting Officer		2012-01-20 18:00:159,384
0		9,384Form 4
BACKER MARK P
VP, Technical Development		2003-07-01 16:55:307,500
0		7,500Form 4
KLINGBELL CORINE
VP, Preclinical Development		2003-07-01 18:06:247,500
0		7,500Form 4
Sarena Francis Willard
VP/Gen Counsel/Secy		2008-09-17 11:44:415,756
0		5,756Form 4
CROSS HERB
Corp Controller/Prin Acctg Off		2008-09-17 11:43:265,031
0		5,031Form 4
LINK MAX
Director		2006-12-22 18:51:575,000
0		5,000Form 4
CALDWELL PATRICK M
VP, Finance and Controller		2003-07-01 17:30:055,000
0		5,000Form 4
LYONS GARY A
Director		2008-08-15 16:23:592,500
0		2,500Form 4
DAWES KAREN A
Chairperson of the Board		2008-04-30 14:27:352,250
0		2,250Form 4
Calcott Peter H
VP, Quality & Compliance		2007-01-29 19:00:411,875
0		1,875Form 4
GRYSKA DAVID W
Director		2020-12-31 18:48:571,387
0		1,387Form 4
Immune Response BioPharma Inc.
Shareholder		2015-06-24 18:20:191
0		1Form 3
Iwanicki David
VP, Sales & Sales Operations		2008-01-03 13:32:130
0		0Form 4
O'Farrell Elizabeth G.
Director		2020-11-24 19:25:360
0		0Form 4
DREWS JURGEN
Director		2004-06-08 20:30:270
0		0Form 4